This page shows the latest Hisun news and features for those working in and with pharma, biotech and healthcare.
of $490m from the transfer of certain product rights to its China-based joint venture with Hisun.
and Pfizer announced plans to work with both Zhejiang Hisun Pharmaceuticals and Shanghai Pharmaceuticals Co.
Pfizer has announced it is to work with Zhejiang Hisun Pharmaceuticals to develop and market generic drugs in China. ... Hua Bai, CEO and president of Hisun Pharmaceuticals, stated that such deals were the way forward for the company.
Hisun Pharma to form JV with Spanish company. Zhejiang Hisun Pharmaceutical, which is one of China's biggest active pharmaceutical ingredient producers, has signed a letter of intent with an unnamed
More from news
Approximately 0 fully matching, plus 4 partially matching documents found.
Watson continues to extend its women's health franchise. Picking up on several of last year's deal trends, Zhejiang Hisun reported the closure of an exclusive option to access ... So the deployment of an option excluding third party access in this case
Several joint venture deals between MNCs and Chinese players have been sealed recently: Hisun with Pfizer, Simcere with Merck and Fosun with Lonza.
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
We live in a hyper-connected world. This has clear benefits for the health of our communities, our businesses and our...